Clinical Trial Update: Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating rituximab induction and living donation on immunoregulation and virus control in kidney transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: University of Giessen | Conditions: Kidney Transplantation, Rituximab (RTx) | Phase 2 | Status: COMPLETED